Maximum Protection, Ultimate Prevention with the unique purifying MPXX™ technology.


We are delighted to announce and proud to launch our new product line of MPXX™ treated synthetic rubber gloves. Working tirelessly to deliver safer and higher quality products we now apply our unique purifying technology to high-grade nitrile examination gloves allowing you to work with the cleanest gloves on the market. Our innovative technology cuts the chemical residues to undetectable levels, including the carcinogenic migratable N-Nitrosamines..


Click here to download the e-flyer

If you’re interested in the origins of MPXX™, read below. Otherwise…

Make prevention your priority. Request your samples or place your order now.

Protection, Prevention, Perfect fit and feel

  • Optimal protection against allergy type IV and skin reactions thanks to the MPXX™ technology
  • Undetectable chemical residues
  • High barrier protection, beaded cuff
  • Better puncture and chemical resistance properties compared with other glove materials
  • Unparalleled comfort & fit
  • Superior dexterity & tactility
  • Micro-textured finger surface for excellent grip

Safety and comfort. No compromise.

Our teams of experts apply the purifying MPXX™ technology to supreme quality, soft and stretchy nitrile gloves thereby upgrading disposable medical gloves to the ultimate preventive tool. Our end product is a clean glove that combines exceptional comfort with maximum protection and ultimate prevention.

Committed to quality

Tests conducted in international accredited laboratories demonstrate that MPXX™ treated products boast undetectable levels of chemical residues and the lowest cytotoxicity levels in the industry (Grade 0 -1).

Synthectic rubber and allergy type IV.

The development of synthetic gloves stems from a potential sensitivity to natural rubber latex proteins causing allergy type I. However, the chemicals used to manufacture both natural and synthetic rubber gloves are responsible for the dramatic increase of irritant and allergic contact dermatitis (allergy type IV) among health professionals. Although allergy type IV is not as severe as allergy type I, it can be chronic and difficult to cure causing frequent absenteeism and a potential career change if it hinders the individuals from performing their tasks.

A brief history and origins of MPXX

Our passion & expertise date back to 1995, when the founder of the Dutch R & D company BUDEV, strongly aware of the importance of the growing latex allergy & occupational safety issues, initiated the research & development of MPXX™. In co-operation with scientific partner-organizations such as the Erasmus University Medical Centre in Rotterdam & the Malaysian Rubber Board, Budev BV developed and patented different technologies, including MPXX™.

The objective was to implement MPXX™ technology worldwide with selected dynamic partners who had an excellent track-record in quality & efficiency within the medical and industrial sector & opted to apply the MPXX™ technology first on medical gloves. In 2015 we changed our name to MPXX, matching it with our technology which represents the core of our business and key to our success.